Kaiser Permanente affiliates will pay $556 million to settle a lawsuit that alleged the health care giant committed Medicare ...
How-To Geek on MSN
The 5 best Linux terminal-based file managers
It blends Vim-style navigation with strong visual feedback, which makes it one of the most approachable keyboard-driven file ...
The White House had threatened to withhold the Smithsonian's funding if it did not send more documentation on its exhibits ...
In Dec 2024, LIS Technologies Inc. was selected as one of six domestic companies to participate in the Low-Enriched Uranium (LEU) Enrichment Acquisition Program. This initiative allocates up to $3.4 ...
8hon MSN
Eight Democrats vie for chance to face off against lone Republican candidate in district clerk race
The victor who emerges from a crowded eight-candidate Democratic ticket will face off against the lone Republican running for ...
My car mostly runs on electricity and has a tiny two-gallon gas backup. On long trips, I stop at gas stations more often than ...
Opinion
9hon MSNOpinion
Windbag Trump losing his fight against offshore turbines in NE (The Republican editorials)
The following editorial is from the opinion page of The Republican newspaper in Springfield. It reflects views of the newspaper’s leadership and not necessarily those of MassLive. Readers are invited ...
Affiliates of Kaiser Permanente with major operations in Oakland and beyond have agreed to pay $556 million to settle federal ...
The president was barely a year into his administration when a health care debate began to consume Washington. On Capitol ...
As President Trump approaches one year back in office, the policies his administration pursues — and how those policies are ...
Clear, Phased Exploration Strategy to Advance the Project – The Technical Report outlines a two-phase exploration program, beginning with drill validation of historical intercepts followed by ...
AbCellera (Nasdaq: ABCL) today announced that the first patients have been dosed in the Phase 2 portion of its ongoing Phase 1/2 clinical trial for ABCL635. ABCL635 is a potential first-in-class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results